"FDA-approved" labeling legislation
Executive SummaryHouse Commerce/Health Subcmte. on May 2 passed in a unamimous voice vote Chairman Waxman's (D-Calif.) bill to lift the prohibition against stating in Rx drug labeling and advertising that a product has been approved by FDA. Ranking Minority Member Madigan (R-III.) said that although there remains "an outstanding problem" regarding how to handle DESI drugs still under FDA review, it may be resolved by the time the measure (HR 2244) is considered by the full cmte.
You may also be interested in...
Full, planned acquisition of Tokyo-based operation will give US biotech giant a firmer foothold in key market and new platform for Otezla growth.
Quanta Dialysis is linking up with B. Braun Avitum UK to support patients with Quanta’s personal hemodialysis device in the home. See what Quanta CEO John Milad said about it here.
Cosmetics Europe’s Director-General John Chave discusses next steps in the European Union’s proposed drive to ban manufactured microplastic in all cosmetic products. Industry continues to fight for something more proportionate, but it’s up against powerful forces in today’s European theater.